Jannis Kountouras (J Kountouras)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 31

Top Topics

Insulin Resistance

Ulcerative Colitis

Helicobacter Pylori

Top Venues

Alimentary pharmacology & therapeutics

Liver international : official journal of the International Association for the Study of the Liver

Journal of gastroenterology and hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Jannis Kountouras, Stergios A Polyzos, Evangelos Kazakos, Ioannis S Papanikolaou, Christos Liatsos, Elisabeth Vardaka, Dimitrios Tzilves, Efthimia Vlachaki
Letter: Helicobacter pylori and metabolic syndrome-related von Willebrand factor and plasminogen activator inhibitor-1 activity levels for outcome prediction of advanced chronic liver disease. Alimentary pharmacology & therapeutics 60 (4) (2024)
Jannis Kountouras, C Zavos, E Vardaka, F Kyrailidi, M C Mouratidou, M Tzitiridou-Chatzopoulou, E Orovou, M Touloumtzi, Ioannis S Papanikolaou, E Kazakos
Helicobacter pylori and metabolic syndrome-related adipokines in nonalcoholic fatty liver disease pathophysiology. Journal of gastroenterology and hepatology (2024)
Jannis Kountouras, Evangelos Kazakos, Michael Doulberis, Apostolis Papaefthymiou
Relationship between Helicobacter pylori and metabolic syndrome-related parameters and risk of MASLD. Liver international : official journal of the International Association for the Study of the Liver 44 (9) (2024)
Jannis Kountouras, Stergios A Polyzos, Evangelos Kazakos, Christos Zavos, Nikolaos Grigoriadis, Ioannis S Papanikolaou, Elisabeth Vardaka, Dimitrios Tzilves, Dimitrios Chatzopoulos, Maria Tzitiridou-Chatzopoulou, Maria Touloumtzi, Michael Doulberis, Apostolis Papaefthymiou
Letter: Role of Helicobacter pylori and metabolic syndrome-related insulin resistance and lipotoxicity in the pathogenesis of MAFLD and MASH. Alimentary pharmacology & therapeutics 60 (5) (2024)
Jannis Kountouras, Stergios A Polyzos, Evangelos Kazakos, Ioannis S Papanikolaou, Christos Liatsos, Elisabeth Vardaka, Dimitrios Tzilves, Efthimia Vlachaki
Letter: Helicobacter pylori and metabolic syndrome-related von Willebrand factor and plasminogen activator inhibitor-1 activity levels for outcome prediction of advanced chronic liver disease. Alimentary pharmacology & therapeutics (2024)
Jannis Kountouras, Evangelos Kazakos, Michael Doulberis, Apostolis Papaefthymiou
Relationship between Helicobacter pylori and metabolic syndrome-related parameters and risk of MASLD. Liver international : official journal of the International Association for the Study of the Liver 44 (9) (2024)
Jannis Kountouras, Evangelos Kazakos, Michael Doulberis, Apostolis Papaefthymiou
Relationship between Helicobacter pylori and metabolic syndrome-related parameters and risk of MASLD. Liver international : official journal of the International Association for the Study of the Liver (2024)
Jannis Kountouras, Elisabeth Vardaka, Christos Zavos, Dimitrios Chatzopoulos, Maria Tzitiridou-Chatzopoulou, Dimitrios Tzilves, Georgia Zournatzidou, Foteini Kyrailidou, Maria C Mouratidou
Letter: Potential impact of Helicobacter pylori infection on oesophageal disorders in chronic liver disease. Alimentary pharmacology & therapeutics (2024)
Jannis Kountouras, Stergios A Polyzos, Evangelos Kazakos, Ioannis S Papanikolaou, Christos Liatsos, Elisabeth Vardaka, Dimitrios Tzilves, Efthimia Vlachaki
Letter: Helicobacter pylori and metabolic syndrome-related von Willebrand factor and plasminogen activator inhibitor-1 activity levels for outcome prediction of advanced chronic liver disease. Alimentary pharmacology & therapeutics 60 (4) (2024)
Jannis Kountouras, Stergios A Polyzos, Evangelos Kazakos, Christos Zavos, Nikolaos Grigoriadis, Ioannis S Papanikolaou, Elisabeth Vardaka, Dimitrios Tzilves, Dimitrios Chatzopoulos, Maria Tzitiridou-Chatzopoulou, Maria Touloumtzi, Michael Doulberis, Apostolis Papaefthymiou
Letter: Role of Helicobacter pylori and metabolic syndrome-related insulin resistance and lipotoxicity in the pathogenesis of MAFLD and MASH. Alimentary pharmacology & therapeutics (2024)
Jannis Kountouras, Apostolis Papaefthymiou, Stergios A Polyzos, Evangelos Kazakos, Dimitrios Tzilves, Maria Touloumtzi, Dimitrios Chatzopoulos, Maria Tzitiridou-Chatzopoulou, Christos Liatsos, Christos Zavos, John Kavaliotis, Hasan Kulaksiz, Michael Doulberis
Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities. Alimentary pharmacology & therapeutics 57 (10) (2023)
Jannis Kountouras
Considering the Long-Conflicting Topic of Empirical or Nonconventional Helicobacter pylori Eradication Regimens. Gut and liver (2023)
Jannis Kountouras, Apostolis Papaefthymiou, Stergios A Polyzos, Evangelos Kazakos, Dimitrios Tzilves, Maria Touloumtzi, Dimitrios Chatzopoulos, Maria Tzitiridou-Chatzopoulou, Christos Liatsos, Christos Zavos, John Kavaliotis, Hasan Kulaksiz, Michael Doulberis
Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities. Alimentary pharmacology & therapeutics 57 (10) (2023)
Jannis Kountouras
Thinking of the Long Puzzling Issue of Several Suboptimal Treatments of Helicobacter pylori Infection. The American journal of gastroenterology 118 (11) (2023)
Jannis Kountouras, Apostolis Papaefthymiou, Stergios A Polyzos, Evangelos Kazakos, Dimitrios Tzilves, Maria Touloumtzi, Dimitrios Chatzopoulos, Maria Tzitiridou-Chatzopoulou, Christos Liatsos, Christos Zavos, John Kavaliotis, Hasan Kulaksiz, Michael Doulberis
Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities. Alimentary pharmacology & therapeutics 57 (10) (2023)
Jannis Kountouras, Apostolis Papaefthymiou, Stergios A Polyzos, Evangelos Kazakos, Dimitrios Tzilves, Maria Touloumtzi, Dimitrios Chatzopoulos, Maria Tzitiridou-Chatzopoulou, Christos Liatsos, Christos Zavos, John Kavaliotis, Hasan Kulaksiz, Michael Doulberis
Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities. Alimentary pharmacology & therapeutics 57 (10) (2023)
Jannis Kountouras, Evangelos Kazakos, Anthia Gatopoulou, Stergios A Polyzos, Maria Touloumtzi, Foteini Kyrailidi, Maria C Mouratidou, Aggeliki Stogianni, Elisabeth Vardaka
Letter: Histological changes among asymptomatic chronic HBV carriers with normal alanine aminotransferase levels. Alimentary pharmacology & therapeutics 58 (11-12) (2023)
Jannis Kountouras, Apostolis Papaefthymiou, Stergios A Polyzos, Christos Liatsos, Maria Tzitiridou-Chatzopoulou, Dimitrios Chatzopoulos, Elisabeth Vardaka, Dimitra Gialamprinou, Georgios Kotronis, Tharshika Thavayogarajah, Michael Doulberis
Adverse Outcomes of E-cigarette in Inflammatory Bowel Disease. Digestive diseases and sciences (2022)
Jannis Kountouras, Apostolis Papaefthymiou, Stergios A Polyzos, Foteini Kyrailidi, Michael Doulberis
Potential impact of Helicobacter pylori-related metabolic syndrome on arterial hypertension outcomes. American journal of hypertension (2022)
Apostolis Papaefthymiou, Spyros Potamianos, Antonis Goulas, Michael Doulberis, Jannis Kountouras, Stergios A Polyzos
Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents. Journal of Crohn's & colitis 16 (5) (2022)
Jannis Kountouras, Apostolis Papaefthymiou, Stergios A Polyzos, Evangelos Kazakos, Elisabeth Vardaka, Maria Touloumtzi, Maria Tzitiridou-Hatzopoulou, Christos Liatsos, Ioanna-Konstantina Sgantzou, Jürg Knuchel, Michael Doulberis
Impact of Active Helicobacter pylori Infection-related Metabolic Syndrome on Systemic Arterial Hypertension. Arquivos brasileiros de cardiologia 119 (3) (2022)
Jannis Kountouras, Michael Doulberis, Evangelos Kazakos, Sofia K Tzika, Elizabeth Vardaka, Christos Liatsos, Apostolis Papaefthymiou
Correspondence on 'Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis' by Rizos et al . Heart (British Cardiac Society) 108 (8) (2022)
Jannis Kountouras, Apostolis Papaefthymiou, Stergios A Polyzos, Christos Liatsos, Elisabeth Vardaka, Maria Touloumtzi, Maria Tzitiridou-Chatzopoulou, Dimitrios Chatzopoulos, Michael Doulberis
Letter to the Editor Regarding "The Association of Helicobacter pylori, Eradication, and Early Complications of Laparoscopic Sleeve Gastrectomy" by Abeid et al. Obesity surgery 32 (6) (2022)
Jannis Kountouras, Michael Doulberis, Stergios A Polyzos, E Kazakos, E Vardaka, M Touloumtzi, A Manolakis, M Tzitiridou-Chatzopoulou, C Liatsos, E S Sotiriades, S Ntona, Apostolis Papaefthymiou
Impact of Helicobacter pylori-related metabolic syndrome with hyperhomocysteinemia on extragastric pathologies. Journal of gastroenterology and hepatology (2021)
Jannis Kountouras, Apostolis Papaefthymiou, Stergios A Polyzos, Michael Doulberis
A potential impact of Helicobacter pylori-related sarcopenia on severity of portal hypertension. Liver international : official journal of the International Association for the Study of the Liver 41 (5) (2021)
Apostolis Papaefthymiou, Michael Doulberis, Stergios A Polyzos, Panagiotis Katsinelos, Jannis Kountouras
Letter: Helicobacter pylori infection and its role in oesophageal adenocarcinoma. Alimentary pharmacology & therapeutics 51 (11) (2020)
Michael Doulberis, Apostolis Papaefthymiou, David S Srivastava, Aristomenis K Exadaktylos, Panagiotis Katsinelos, Jannis Kountouras, Stergios A Polyzos
Update on the association between non-alcoholic fatty liver disease and Helicobacter pylori infection. International journal of clinical practice 75 (4) (2020)
Apostolis Papaefthymiou, Michael Doulberis, Stergios A Polyzos, Panagiotis Katsinelos, Christos Liatsos, Apostolos Koffas, Evangelos Kazakos, Georgia Deretzi, David S Srivastava, Jannis Kountouras
Letter: Helicobacter pylori in proton pump inhibitor-associated biliary disease. Alimentary pharmacology & therapeutics 51 (2) (2020)
Apostolis Papaefthymiou, Michael Doulberis, Panagiotis Katsinelos, Christos Liatsos, Stergios A Polyzos, Georgios Kotronis, Katerina Papanikolaou, Jannis Kountouras
Impact of nitric oxide's bidirectional role on glaucoma: focus on Helicobacter pylori-related nitrosative stress. Annals of the New York Academy of Sciences 1465 (1) (2019)
Stergios A Polyzos, Jannis Kountouras
CHAI and MACK-3 as noninvasive indices for nonalcoholic steatohepatitis. Liver international : official journal of the International Association for the Study of the Liver 39 (8) (2019)
Stergios A Polyzos, Jannis Kountouras
Helicobacter pylori infection and nonalcoholic fatty liver disease: Time for large clinical trials evaluating eradication therapy. Helicobacter 24 (3) (2019)